Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Monday that its second quarter revenues increased 45 percent year over year.

For the three months ended June 30, the San Diego-based liquid biopsy firm saw $1.2 million in revenues compared to the $822,238 it brought in during the same quarter last year.

According to the company, revenue growth reflects a shift in commercial efforts toward specific segments of the oncology market where Biocept believes its assays can help the most patients: prostate, breast, and lung cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.